| P2093 | author name string | E Nobile-Orazio | |
| | T Umapathi | |
| | JM Léger | |
| | RAC Hughes | |
| P2860 | cites work | Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies | Q28334663 |
| | Multifocal motor neuropathy with conduction block: a study of 24 patients | Q33734400 |
| | Long term follow up of multifocal motor neuropathy with conduction block under treatment | Q33735714 |
| | Multifocal motor neuropathy: response to human immune globulin | Q34062007 |
| | Interobserver agreement for the assessment of handicap in stroke patients. | Q34176187 |
| | Multifocal motor neuropathy. | Q34204618 |
| | Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies | Q35449950 |
| | Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy | Q36317538 |
| | Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study | Q36880697 |
| | Electrophysiological improvement after intravenous immunoglobulin in motor neuropathy with multifocal conduction block | Q39207150 |
| | The clinical and diagnostic role of anti-GM1 antibody testing | Q40792321 |
| | Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy | Q41663344 |
| | Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy | Q41663659 |
| | Multifocal motor neuropathy without overt conduction block | Q41702502 |
| | Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin | Q41766911 |
| | The sensitivity and specificity of anti-GM1 antibody testing | Q42553258 |
| | Treatment of IgM antibody associated polyneuropathies using rituximab | Q43069450 |
| | Plasmapheresis in multifocal motor neuropathy: a case report | Q43071840 |
| | Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? | Q43583532 |
| | Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease | Q43839016 |
| | A computer simulation of conduction block: effects produced by actual block versus interphase cancellation | Q43871919 |
| | Mycophenolate in treatment-resistant inflammatory neuropathies | Q44230238 |
| | Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome | Q44643471 |
| | Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. | Q44873430 |
| | A syndrome of asymmetric limb weakness with motor conduction block | Q44992268 |
| | Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies | Q46163603 |
| | The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy | Q48486772 |
| | Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment | Q48536321 |
| | Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study | Q49125609 |
| | How long is IVIg effective in multifocal motor neuropathy? | Q51021985 |
| | High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. | Q53771496 |
| | Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. | Q53901414 |
| | Motor Neuropathy with Proximal Multifocal Persistent Conduction Block, Fasciculations and Myokymia | Q56608957 |
| | Multifocal motor neuropathy mimicking motor neuron disease: nine cases | Q59270630 |
| | Intravenous immunoglobulin treatment in multifocal motor neuropathy | Q67518467 |
| | Conduction block in clinical practice | Q68016775 |
| | Immunosuppressive treatment in multifocal motor neuropathy | Q68060632 |
| | Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy | Q68075974 |
| | Chronic acquired demyelinating motor neuropathy | Q68258723 |
| | Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome | Q69599049 |
| | Motor neuropathy with multifocal conduction blocks | Q69656919 |
| | A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside | Q69836574 |
| | Pathological findings at the site of conduction block in multifocal motor neuropathy | Q70564756 |
| | Multifocal demyelinating neuropathy with persistent conduction block | Q70680262 |
| | Sensory nerve pathology in multifocal motor neuropathy | Q71004368 |
| | Multifocal motor neuropathy: clinical and electrophysiological findings | Q71787737 |
| | Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study | Q72335038 |
| | Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder | Q72765673 |
| | Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis | Q73090016 |
| | Multifocal motor neuropathy presenting as ophthalmoplegia | Q73115212 |
| | Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities | Q73195249 |
| | Multifocal motor neuropathy and Lewis Sumner syndrome: a clinical spectrum | Q73195253 |
| | AAEM news and comments | Q73195257 |
| | Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy | Q73245639 |
| | Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment | Q73298577 |
| | Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy | Q73343604 |
| | Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? | Q73355928 |
| | Treatment of multifocal motor neuropathy with interferon-beta1A | Q73634320 |
| | 79(th) ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands | Q73739726 |
| | Natural history of 46 patients with multifocal motor neuropathy with conduction block | Q73864084 |
| | Multifocal motor neuropathy | Q74093843 |
| | Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity? | Q74298491 |
| | Deterioration of multifocal motor neuropathy after plasma exchange | Q74575154 |
| | Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab | Q75205847 |
| | Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies | Q77343613 |
| | Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome | Q77758996 |
| | Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy | Q77873391 |
| | Consensus criteria for the diagnosis of multifocal motor neuropathy | Q78735138 |
| | Efficacy of cyclosporine treatment in multifocal motor neuropathy | Q79077971 |
| | Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome | Q80407989 |
| | Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg | Q80847191 |
| P921 | main subject | immunosuppression | Q1455316 |
| | Multifocal motor neuropathy | Q6934690 |
| P577 | publication date | 2005-07-20 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy | |